Inventor · disambiguated record
M. Arshad Siddiqui
Also filed as: SIDDIQUI M A · SIDDIQUI M ARSHAD
52 granted patents·19 pending applications·551 citations·filing 1992–2022
98Inventor score
Files withSCHERING CORP24SYROS PHARMACEUTICALS INC9SIDDIQUI M ARSHAD6IAF BIOCHEM INT5BANTAM PHARMACEUTICAL LLC4
Top patents by PatentIndex Score
71 records- 0197US5696254AProcesses for the diastereoselective synthesis of nucleoside analoguesIAF BIOCHEM INT·Filed 1992·Granted Dec 9, 1997·93 cites·25 claims
- 0295US7488745B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Feb 10, 2009·23 cites·34 claims
- 0393US11040957B2Heteroaromatic compounds useful for the treatment of proliferative diseasesSYROS PHARMACEUTICALS INC·Filed 2018·Granted Jun 22, 2021·7 cites·21 claims
- 0493US7807672B2Compounds that are ERK inhibitorsSCHERING CORP·Filed 2007·Granted Oct 5, 2010·16 cites·23 claims
- 0592US10059690B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·9 cites·19 claims
- 0692US8178553B2Compounds for the treatment of inflammatory disordersLAVEY BRIAN J·Filed 2010·Granted May 15, 2012·46 cites·19 claims
- 0792US7524842B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Apr 28, 2009·19 cites·34 claims
- 0892US7504424B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2006·Granted Mar 17, 2009·24 cites·3 claims
- 0991US10047070B2Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2014·Granted Aug 14, 2018·17 cites·19 claims
- 1091US8569336B2Compounds for the treatment of inflammatory disordersTONG LING·Filed 2009·Granted Oct 29, 2013·44 cites·4 claims
- 1191US5693787AIntermediates in the synthesis of 1,3-oxathiolanyl cytosine nucleoside analoguesIAF BIOCHEM INT·Filed 1995·Granted Dec 2, 1997·37 cites·13 claims
- 1290US5663320AProcesses for the diastereoselective separation of nucleoside analogue synthetic intermediatesIAF BIOCHEM INT·Filed 1995·Granted Sep 2, 1997·35 cites·3 claims
- 1388US7879890B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Feb 1, 2011·6 cites·11 claims
- 1487US7563798B2Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitorsSCHERING CORP·Filed 2006·Granted Jul 21, 2009·11 cites·3 claims
- 1587US5763606AStereoselective synthesis of nucleoside analogues using bicyclic intermediateIAF BIOCHEM INT·Filed 1994·Granted Jun 9, 1998·33 cites·18 claims
- 1686US8546404B2Compounds that are ERK inhibitorsCOOPER ALAN B·Filed 2007·Granted Oct 1, 2013·9 cites·76 claims
- 1786US7772263B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2009·Granted Aug 10, 2010·7 cites·31 claims
- 1886US7687527B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 30, 2010·8 cites·9 claims
- 1986US7576085B2Imidazopyrazines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2005·Granted Aug 18, 2009·10 cites·15 claims
- 2085US10106526B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2015·Granted Oct 23, 2018·5 cites·19 claims
- 2185US8318735B22-aminothiazole-4-carboxylic amides as protein kinase inhibitorsSHIPPS JR GERALD W·Filed 2007·Granted Nov 27, 2012·10 cites·16 claims
- 2284US10906889B2Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2018·Granted Feb 2, 2021·4 cites·32 claims
- 2384US10519135B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2018·Granted Dec 31, 2019·3 cites·18 claims
- 2484US7998961B2Hydantoin derivatives useful as antibacterial agentsSCHERING CORP·Filed 2007·Granted Aug 16, 2011·4 cites·3 claims
- 2584US7511040B2Imidazopyrazines as protein kinase inhibitorsSCHERING CORP·Filed 2007·Granted Mar 31, 2009·8 cites·17 claims
- 2682US7652020B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 26, 2010·5 cites·48 claims
- 2782US7638513B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Dec 29, 2009·6 cites·5 claims
- 2879US11325903B2Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseasesBANTAM PHARMACEUTICAL LLC·Filed 2017·Granted May 10, 2022·2 cites·24 claims
- 2979US10865206B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2019·Granted Dec 15, 2020·1 cites·25 claims
- 3079US8278337B2Substituted pyridines that are JNK inhibitorsBELANGER DAVID B·Filed 2007·Granted Oct 2, 2012·8 cites·25 claims
- 3178US11602526B2Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating theretoBANTAM PHARMACEUTICAL LLC·Filed 2020·Granted Mar 14, 2023·1 cites·27 claims
- 3278US8293747B2Heterocyclic amide compounds as protein kinase inhibitorsREDDY PANDURANGA ADULLA P·Filed 2008·Granted Oct 23, 2012·5 cites·2 claims
- 3377US10537558B2Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating theretoBANTAM PHARMACEUTICAL LLC·Filed 2016·Granted Jan 21, 2020·3 cites·28 claims
- 3477US9206142B2Anilinopiperazine derivatives and methods of use thereofSHIPPS JR GERALD W·Filed 2007·Granted Dec 8, 2015·4 cites·21 claims
- 3575US8591943B2Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitorsDENG YONGQI·Filed 2010·Granted Nov 26, 2013·6 cites·2 claims
- 3675US7557104B2Imidazopyrazines as protein kinase inhibitorsSCHERING CORP·Filed 2007·Granted Jul 7, 2009·2 cites·39 claims
- 3775US7553864B2Compounds for the treatment of inflammatory disorders and microbial diseasesSCHERING CORP·Filed 2006·Granted Jun 30, 2009·2 cites·14 claims
- 3874US7683088B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Mar 23, 2010·1 cites·19 claims
- 3972US8541572B2Compounds for the treatment of inflammatory disordersKOZLOWSKI JOSEPH A·Filed 2009·Granted Sep 24, 2013·2 cites·4 claims
- 4069US7446195B2High affinity thiophene-based and furan-based kinase ligandsSCHERING CORP·Filed 2006·Granted Nov 4, 2008·1 cites·10 claims
- 4167US8927562B2Fused tricyclic inhibitors of mammalian target of rapamycinMENG ZHAOYANG·Filed 2011·Granted Jan 6, 2015·1 cites·8 claims
- 4265US8883801B2Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitorsZHAO LIANYUN·Filed 2011·Granted Nov 11, 2014·1 cites·13 claims
- 4365US2021061803A1Inhibitors of cyclin-dependent kinase 7 (cdk7)SYROS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4464US2023076820A1Substituted Pyrazole Compounds and Methods of Using Them for Treatment of Hyperproliferative DiseasesBANTAM PHARMACEUTICAL LLC·Filed 2022·Application pending·0 cites
- 4560US2016264551A1Heteroaromatic compounds useful for the treatment of prolferative diseasesSYROS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4659US8609675B2Fused Tricyclic Compounds as novel mTOR inhibitorsCHENG CLIFF C·Filed 2010·Granted Dec 17, 2013·1 cites·14 claims
- 4758US8669259B2Heterocyclic amide compounds as protein kinase inhibitorsREDDY PANDURANGA P ADULLA·Filed 2010·Granted Mar 11, 2014·1 cites·18 claims
- 4856US8476278B2Thiazole Derivatives as protein kinase inhibitorsREDDY PANDURANGA ADULLA P·Filed 2008·Granted Jul 2, 2013·0 cites·2 claims
- 4955US2011212080A1Urea derivatives as antibacterial agentsMANSOOR UMAR FARUK·Filed 2009·Application pending·0 cites
- 5053US6057314ALow molecular weight bicyclic thrombin inhibitorsIAF BIOCHEM INT·Filed 1997·Granted May 2, 2000·6 cites·8 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when M. Arshad Siddiqui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →